Matches in SemOpenAlex for { <https://semopenalex.org/work/W2777508311> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2777508311 abstract "Introduction: In a small phase II trial in Japanese patients with IPF, there was a trend towards lower nintedanib exposure when nintedanib 150 mg bid was added to pirfenidone than when given alone Aim: To explore the PK of nintedanib with add-on pirfenidone. Methods: After a 4–5 week run-in with nintedanib 150 mg bid, patients with IPF were randomised to open-label nintedanib 150 mg bid with add-on pirfenidone or nintedanib 150 mg bid alone for 12 weeks. In the combination group, patients received pirfenidone 267 mg tid from randomisation to week 1, 534 mg tid from week 1 to week 2, 801 mg tid from week 2. Pre-dose plasma trough concentrations were measured at baseline (for nintedanib) and at weeks 2 and 4 (for nintedanib and pirfenidone). Results: Pre-dose pirfenidone gMean (gCV%) concentrations were 1120 (122) and 1220 (91) ng/mL at weeks 2 and 4, respectively. Pre-dose plasma trough concentrations of nintedanib were similar at each time point, irrespective of whether nintedanib 150 mg bid was administered alone or with add-on pirfenidone 534 mg or 801 mg tid (table). Moderate to high variability was observed in both groups. Conclusion: In patients with IPF, nintedanib plasma trough concentrations were similar when nintedanib was administered alone or with add-on pirfenidone; however, data from a dedicated drug–drug interaction study are needed to draw robust conclusions." @default.
- W2777508311 created "2018-01-05" @default.
- W2777508311 creator A5006969715 @default.
- W2777508311 creator A5007804440 @default.
- W2777508311 creator A5012539336 @default.
- W2777508311 creator A5019441565 @default.
- W2777508311 creator A5033032729 @default.
- W2777508311 creator A5035302108 @default.
- W2777508311 creator A5050978023 @default.
- W2777508311 creator A5057513448 @default.
- W2777508311 creator A5068145736 @default.
- W2777508311 creator A5079519206 @default.
- W2777508311 creator A5091576695 @default.
- W2777508311 date "2017-09-01" @default.
- W2777508311 modified "2023-10-01" @default.
- W2777508311 title "Late Breaking Abstract - Pharmacokinetics (PK) of nintedanib with add-on pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): results from INJOURNEY" @default.
- W2777508311 doi "https://doi.org/10.1183/1393003.congress-2017.pa907" @default.
- W2777508311 hasPublicationYear "2017" @default.
- W2777508311 type Work @default.
- W2777508311 sameAs 2777508311 @default.
- W2777508311 citedByCount "0" @default.
- W2777508311 crossrefType "proceedings-article" @default.
- W2777508311 hasAuthorship W2777508311A5006969715 @default.
- W2777508311 hasAuthorship W2777508311A5007804440 @default.
- W2777508311 hasAuthorship W2777508311A5012539336 @default.
- W2777508311 hasAuthorship W2777508311A5019441565 @default.
- W2777508311 hasAuthorship W2777508311A5033032729 @default.
- W2777508311 hasAuthorship W2777508311A5035302108 @default.
- W2777508311 hasAuthorship W2777508311A5050978023 @default.
- W2777508311 hasAuthorship W2777508311A5057513448 @default.
- W2777508311 hasAuthorship W2777508311A5068145736 @default.
- W2777508311 hasAuthorship W2777508311A5079519206 @default.
- W2777508311 hasAuthorship W2777508311A5091576695 @default.
- W2777508311 hasConcept C112705442 @default.
- W2777508311 hasConcept C126322002 @default.
- W2777508311 hasConcept C126894567 @default.
- W2777508311 hasConcept C2777714996 @default.
- W2777508311 hasConcept C2778341716 @default.
- W2777508311 hasConcept C2779832356 @default.
- W2777508311 hasConcept C2780171596 @default.
- W2777508311 hasConcept C71924100 @default.
- W2777508311 hasConcept C90924648 @default.
- W2777508311 hasConcept C98274493 @default.
- W2777508311 hasConceptScore W2777508311C112705442 @default.
- W2777508311 hasConceptScore W2777508311C126322002 @default.
- W2777508311 hasConceptScore W2777508311C126894567 @default.
- W2777508311 hasConceptScore W2777508311C2777714996 @default.
- W2777508311 hasConceptScore W2777508311C2778341716 @default.
- W2777508311 hasConceptScore W2777508311C2779832356 @default.
- W2777508311 hasConceptScore W2777508311C2780171596 @default.
- W2777508311 hasConceptScore W2777508311C71924100 @default.
- W2777508311 hasConceptScore W2777508311C90924648 @default.
- W2777508311 hasConceptScore W2777508311C98274493 @default.
- W2777508311 hasLocation W27775083111 @default.
- W2777508311 hasOpenAccess W2777508311 @default.
- W2777508311 hasPrimaryLocation W27775083111 @default.
- W2777508311 hasRelatedWork W2103647780 @default.
- W2777508311 hasRelatedWork W2116462976 @default.
- W2777508311 hasRelatedWork W2377147785 @default.
- W2777508311 hasRelatedWork W2754685293 @default.
- W2777508311 hasRelatedWork W2779387655 @default.
- W2777508311 hasRelatedWork W2890575335 @default.
- W2777508311 hasRelatedWork W2965586691 @default.
- W2777508311 hasRelatedWork W2990301722 @default.
- W2777508311 hasRelatedWork W2990305875 @default.
- W2777508311 hasRelatedWork W2992887668 @default.
- W2777508311 hasRelatedWork W3088912120 @default.
- W2777508311 hasRelatedWork W3096731668 @default.
- W2777508311 hasRelatedWork W3174052665 @default.
- W2777508311 hasRelatedWork W3193840798 @default.
- W2777508311 hasRelatedWork W1775621272 @default.
- W2777508311 isParatext "false" @default.
- W2777508311 isRetracted "false" @default.
- W2777508311 magId "2777508311" @default.
- W2777508311 workType "article" @default.